NCT00499291 2023-05-25
Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Advanced or Refractory Solid Tumors
Eastern Cooperative Oncology Group
Phase NA Withdrawn
Clinical Trials
6 trialsNCT04368130 2022-10-14
SIGNAL
Dana-Farber Cancer Institute
Phase NA Withdrawn
NCT03902379 2021-04-19
Web-Based Coping and Communication Skills Intervention in Improving Psychological Adaptation in Patients With Gynecological Cancer
Rutgers, The State University of New Jersey
Phase NA Withdrawn
NCT02530606 2018-11-28
Photoacoustic Imaging in Detecting Ovarian or Fallopian Tube Cancer
Stanford University
Phase NA Withdrawn
NCT00551265 2017-07-14
Oregovomab With or Without Cyclophosphamide in Treating Patients With Stage III or Stage IV Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer That Responded to Second-Line Chemotherapy
GOG Foundation
Phase NA Withdrawn
NCT01228942 2014-06-06
A Prospective Trial of COXEN Chemotherapy Prediction
University of Virginia
Phase NA Withdrawn